期刊
MOLECULAR PHARMACEUTICS
卷 9, 期 10, 页码 2912-2923出版社
AMER CHEMICAL SOC
DOI: 10.1021/mp300237z
关键词
QSAR; artificial neural networks; molecular fingerprints; bioactivity prediction; cannabinoid; CB2; virtual screening
资金
- NIH [R01DA025612, R21HL109654, P50GM067082]
- NIH as part of the HHMI-NIBIB Interfaces Initiative under the Joint CMU-Pitt Computational Biology Ph.D. program at the Carnegie Mellon University [T32 EB009403]
- University of Pittsburgh
In this manuscript, we have reported a novel 2D fingerprint-based artificial neural network QSAR (FANN-QSAR) method in order to effectively predict biological activities of structurally diverse chemical ligands. Three different types of fingerprints, namely, ECFP6, FP2 and MACCS, were used in FANN-QSAR algorithm development, and FANN-QSAR models were compared to known 3D and 2D QSAR methods using five data sets previously reported. In addition, the derived models were used to predict GPCR cannabinoid ligand binding affinities using our manually curated cannabinoid ligand database containing 1699 structurally diverse compounds with reported cannabinoid receptor subtype CB2 activities. To demonstrate its useful applications, the established FANN-QSAR algorithm was used as a virtual screening tool to search a large NCI compound database for lead cannabinoid compounds, and we have discovered several compounds with good CB2 binding affinities ranging from 6.70 nM to 3.75 mu M. To the best of our knowledge, this is the first report for a fingerprint-based neural network approach validated with a successful virtual screening application in identifying lead compounds. The studies proved that the FANN-QSAR method is a useful approach to predict bioactivities or properties of ligands and to find novel lead compounds for drug discovery research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据